Pharmacokinetics of the B-Cell Lymphoma 2 (Bcl-2) Inhibitor Venetoclax in Female Subjects with Systemic Lupus Erythematosus.
about
Pharmacokinetics of the B-Cell Lymphoma 2 (Bcl-2) Inhibitor Venetoclax in Female Subjects with Systemic Lupus Erythematosus.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Pharmacokinetics of the B-Cell ...... Systemic Lupus Erythematosus.
@en
Pharmacokinetics of the B-Cell Lymphoma 2
@nl
type
label
Pharmacokinetics of the B-Cell ...... Systemic Lupus Erythematosus.
@en
Pharmacokinetics of the B-Cell Lymphoma 2
@nl
prefLabel
Pharmacokinetics of the B-Cell ...... Systemic Lupus Erythematosus.
@en
Pharmacokinetics of the B-Cell Lymphoma 2
@nl
P2093
P2860
P1476
Pharmacokinetics of the B-Cell ...... h Systemic Lupus Erythematosus
@en
P2093
Jeroen K Medema
Jiewei Zeng
Mukul Minocha
P2860
P2888
P304
P356
10.1007/S40262-017-0625-2
P577
2018-09-01T00:00:00Z